From: Jeanie Herbert
Sent: January 4, 2016
Subject: File No. 4-691

As a public company, we support recommendations from NASDAQ, and other public companies, for the adoption of rules to require investors to publicly disclose their short positions in exact parity with the mandatory disclosures applicable to long investors.

We believe that the inequality between the reporting of long and short positions is out of balance with today’s transparent markets, leaving public companies and their investors without important information necessary to ensure fair and efficient markets.

Revance Therapeutic, Inc.

Jeanie Herbert

Senior Director of Investor Relations